Close

BIO Puts Forth Gene Therapy Oversight Proposal

Dec 7 1999
WASHINGTON, D.C. (Dec. 7, 1999) -- The Biotechnology Industry Organization (BIO) will present alternatives to proposed guidelines for reporting adverse patient events in gene therapy clinical...

The Passing of Bob Swanson

Dec 6 1999
(Carl Feldbaum, president of BIO, today issued the following statement upon the death of Bob Swanson, co-founder of Genentech):

Washington, D.C. (December 6, 1999) -- ôAs a co-founder of...

Sound Evidence, Not Politics or Trade Discrimination Should Be Used to Assess Biotech Foods

Nov 24 1999
(Carl B. Feldbaum, president of the Biotechnology Industry Organization, issued the following statement prior to the start of the World Trade Organization's Third Ministerial Conference in...

Senate Declares January 2000 National Biotechnology Month

Nov 23 1999
See Senate Resolution 200 below

WASHINGTON, D.C. (Nov. 23, 1999) -- The Biotechnology Industry Organization (BIO) applauds the U.S. Senate for...

Biotech Gets Big Boost From Bills Enacted by Congress

Nov 22 1999
WASHINGTON, D.C. (Nov. 22, 1999) -- Included in the 2000 budget legislation passed by Congress are three measures that give a major boost to the biotechnology industry's efforts to develop new life...

Scientific and Food Safety Issues Statement (The Food and Drug Administration Public Meeting)

Nov 18 1999

The Biotechnology Industry Organization (BIO) is pleased to be invited by the Food and Drug Administration (FDA) to participate on the Food Safety Panel for this public meeting. I am L. Val...

Public Information Issues Statement (The Food and Drug Administration Public Meeting)

Nov 18 1999

Thank you for inviting the Biotechnology Industry Organization (BIO) to provide a statement on the Food and Drug Administration's policy on information issues related to products developed...

BIO Supports FDA Public Meetings On Biotech Foods

Nov 16 1999
WASHINGTON, D.C. (Nov. 16, 1999) -- The Biotechnology Industry Organization (BIO) fully concurs with the U.S. Food and Drug Administration's (FDA) initiative to hold public meetings to discuss the...

BIO Statement of FDA Food Hearing

Nov 16 1999
WASHINGTON, D.C. -- (Carl B. Feldbaum, president of the Biotechnology Industry Organization, issued the following statement in advance of the Food and Drug Administration's upcoming hearing on...

BIO Responds to Labeling Bill

Nov 10 1999
(Michael J. Phillips, Ph.D, Executive Director for Food & Agriculture, issued the following statement in response to Congressman Kucinich's legislation calling for the labeling of genetically...